---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-072249"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:51:30.741651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Prelude Therapeutics posts corporate presentation and SMARCA degrader educational series

## Summary
- Company furnished a corporate presentation (Exhibit 99.1) dated June 2024.
- Launched educational video series on SMARCA degraders available via investor website.
- No financial results, clinical data, or material business changes disclosed.

## SEC filing metadata
- accession: 0000950170-24-072249
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000095017024072249/0000950170-24-072249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000095017024072249/prld-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-072249
- JSON: https://secwatch.observer/filing/0000950170-24-072249.json
- Plain text: https://secwatch.observer/filing/0000950170-24-072249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.